- Home
- PRTA vs OPRX Comparison
PRTA vs OPRX Comparison
Compare PRTA & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- OPRX
- Stock Information
- Founded
- PRTA 2012
- OPRX 2006
- Country
- PRTA Ireland
- OPRX United States
- Employees
- PRTA N/A
- OPRX N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- OPRX Business Services
- Sector
- PRTA Health Care
- OPRX Consumer Discretionary
- Exchange
- PRTA Nasdaq
- OPRX Nasdaq
- Market Cap
- PRTA 472.1M
- OPRX 380.6M
- IPO Year
- PRTA N/A
- OPRX N/A
- Fundamental
- Price
- PRTA $9.92
- OPRX $19.55
- Analyst Decision
- PRTA Buy
- OPRX Buy
- Analyst Count
- PRTA 9
- OPRX 8
- Target Price
- PRTA $13.14
- OPRX $12.19
- AVG Volume (30 Days)
- PRTA 785.0K
- OPRX 330.0K
- Earning Date
- PRTA 11-11-2025
- OPRX 11-12-2025
- Dividend Yield
- PRTA N/A
- OPRX N/A
- EPS Growth
- PRTA N/A
- OPRX N/A
- EPS
- PRTA N/A
- OPRX N/A
- Revenue
- PRTA $10,341,000.00
- OPRX $104,748,000.00
- Revenue This Year
- PRTA N/A
- OPRX $17.92
- Revenue Next Year
- PRTA $602.32
- OPRX $10.91
- P/E Ratio
- PRTA N/A
- OPRX N/A
- Revenue Growth
- PRTA N/A
- OPRX 25.89
- 52 Week Low
- PRTA $4.32
- OPRX $3.78
- 52 Week High
- PRTA $18.88
- OPRX $20.85
- Technical
- Relative Strength Index (RSI)
- PRTA 55.31
- OPRX 57.32
- Support Level
- PRTA $9.98
- OPRX $18.10
- Resistance Level
- PRTA $10.90
- OPRX $20.85
- Average True Range (ATR)
- PRTA 0.47
- OPRX 1.17
- MACD
- PRTA -0.06
- OPRX 0.08
- Stochastic Oscillator
- PRTA 23.93
- OPRX 70.64
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.